The facility was developed as part of GlaxoSmithKline -Economic Development Board (GSK-EDB) under the 10-yr Singapore Manufacturing Roadmap.

–

The aim

• Develop advanced manufacturing technology
• Accelerate supply when novel drug gets into pipeline to patients
• Singapore brand in high quality pharmaceutical manufacturing
• Develop any intellectual properties arising from the partnership
• Develop skilled workers in Singapore

Reference

1. Pharma giant GSK opens $130 mil manufacturing facility in Singapore (https://www.edb.gov.sg/en/news-and-events/news/pharma-giant-gsk-opens-130m-manufacturing-facility-in-singapore.html, 5 Jul 2019)